Skip to main content
Caplight Logo









Cure Capital Advisors

Cure Capital Advisors

Overview

Cure Capital Advisors is a London-based venture capital asset manager that invests in and co-invests in health tech companies.

Portfolio Companies

1

Investments

Cure Capital Advisors investments
CompanyDateStageLead
CaresyntaxAug 2024DebtCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Cure Capital Advisors based?

Cure Capital Advisors is headquartered in London, United Kingdom.

When was Cure Capital Advisors founded?

Founding year information for Cure Capital Advisors is not publicly available.

How many portfolio companies does Cure Capital Advisors have?

Cure Capital Advisors has 1 portfolio company in Caplight's dataset.

What are some companies in Cure Capital Advisors's portfolio?

Portfolio companies visible on Caplight include Caresyntax.

What was Cure Capital Advisors's most recent investment shown here?

Cure Capital Advisors's most recent investment in this portfolio sample was in Caresyntax in 2024.

What sectors does Cure Capital Advisors focus on?

Cure Capital Advisors focuses on Healthcare & Life Sciences, Enterprise Software.

What company stages does Cure Capital Advisors focus on?

Cure Capital Advisors typically invests at the Mid stage.

Firmographic Details

HeadquartersLondon
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?